These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 24518659
1. The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells. Zhan JK, Wang YJ, Wang Y, Wang S, Tan P, Huang W, Liu YS. Can J Cardiol; 2014 May; 30(5):568-75. PubMed ID: 24518659 [Abstract] [Full Text] [Related]
2. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ. J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [Abstract] [Full Text] [Related]
3. Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway. Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P, Huang W, Liu YS. Exp Cell Res; 2014 May 01; 323(2):352-8. PubMed ID: 24607448 [Abstract] [Full Text] [Related]
6. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Wen P, Cao H, Fang L, Ye H, Zhou Y, Jiang L, Su W, Xu H, He W, Dai C, Yang J. Exp Cell Res; 2014 Apr 01; 322(2):302-12. PubMed ID: 24486760 [Abstract] [Full Text] [Related]
7. Nitric oxide regulates vascular calcification by interfering with TGF- signalling. Kanno Y, Into T, Lowenstein CJ, Matsushita K. Cardiovasc Res; 2008 Jan 01; 77(1):221-30. PubMed ID: 18006450 [Abstract] [Full Text] [Related]
8. Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation. Ciceri P, Volpi E, Brenna I, Arnaboldi L, Neri L, Brancaccio D, Cozzolino M. Nephrol Dial Transplant; 2012 Jan 01; 27(1):122-7. PubMed ID: 21613385 [Abstract] [Full Text] [Related]
10. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL. Arterioscler Thromb Vasc Biol; 2014 May 01; 34(5):1002-10. PubMed ID: 24578384 [Abstract] [Full Text] [Related]
11. Mammalian target of rapamycin: a novel pathway in vascular calcification. Montezano AC, Touyz RM. Can J Cardiol; 2014 May 01; 30(5):482-4. PubMed ID: 24698657 [No Abstract] [Full Text] [Related]
12. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway. Zhan JK, Tan P, Wang YJ, Wang Y, He JY, Tang ZY, Huang W, Liu YS. Cardiovasc Diabetol; 2014 Nov 19; 13():153. PubMed ID: 25407893 [Abstract] [Full Text] [Related]
16. Adiponectin inhibits vascular smooth muscle cell calcification induced by beta-glycerophosphate through JAK2/STAT3 signaling pathway. Lu Y, Ma Y, Wang R, Sun J, Guo B, Wei R, Jia Y. J Biosci; 2019 Sep 19; 44(4):. PubMed ID: 31502564 [Abstract] [Full Text] [Related]